ROBERT D PATTERSON, MD
Medical Practice at Blossom St, Lexington, MA
License number
Massachusetts 28842
Category
Medical Practice
Type
Specialist
License number
Massachusetts 28842
Category
Medical Practice
Type
Research Study
Address
Address
21 Blossom St, Lexington, MA 02421
Phone
(617) 510-1318
Personal information
See more information about ROBERT D PATTERSON at radaris.comName
Address
Phone
4 Burnap St, Wilmington, MA 01887
516 Thicket St, S Weymouth, MA 02190
Professional information
See more information about ROBERT D PATTERSON at trustoria.com
Dr. Robert D Patterson, Lexington MA - MD (Doctor of Medicine)
Dr. Robert D Patterson, Lexington MA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
21 Blossom St, Lexington 02421
Certifications:
Psychiatry, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
Graduated: 1964
Milwaukee Co Hosp
McLean Hosp
Harvard University
George Washington University / School of Medicine And Health Sciences
Graduated: 1964
Milwaukee Co Hosp
McLean Hosp
Harvard University
Genetic Data Analysis And Database Tools
Genetic Data Analysis And Database Tools
US Patent:
2009009, Apr 9, 2009
Filed:
Feb 14, 2008
Appl. No.:
12/031327
Inventors:
Howard C. Coleman - Seattle WA, US
Jessica Oesterheld - Bath ME, US
Robert D. Patterson - Lexington MA, US
Jessica Oesterheld - Bath ME, US
Robert D. Patterson - Lexington MA, US
Assignee:
Genelex, Inc - Seattle WA
International Classification:
G06Q 50/00
US Classification:
705 3, 705 2
Abstract:
A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.
Genetic Data Analysis And Database Tools
Genetic Data Analysis And Database Tools
US Patent:
8311851, Nov 13, 2012
Filed:
Dec 9, 2011
Appl. No.:
13/316144
Inventors:
Robert D Patterson - Lexington MA, US
Jessica Oesterheld - Bath ME, US
Howard C Coleman - Seattle WA, US
Jessica Oesterheld - Bath ME, US
Howard C Coleman - Seattle WA, US
Assignee:
Genelex Corp - Seattle WA
International Classification:
G06Q 40/00
US Classification:
705 2, 705 3
Abstract:
A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.
Genetic Data Analysis And Database Tools
Genetic Data Analysis And Database Tools
US Patent:
2013006, Mar 14, 2013
Filed:
Oct 8, 2012
Appl. No.:
13/647246
Inventors:
Jessica Oesterheld - Bath ME, US
Robert D. Patterson - Lexington MA, US
Howard C. Coleman - Seattle WA, US
Robert D. Patterson - Lexington MA, US
Howard C. Coleman - Seattle WA, US
Assignee:
GENELEX CORP - Seattle WA
International Classification:
G06Q 50/22
US Classification:
705 2
Abstract:
A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.
Genetic Data Analysis And Database Tools
Genetic Data Analysis And Database Tools
US Patent:
2012014, Jun 7, 2012
Filed:
Dec 9, 2011
Appl. No.:
13/316354
Inventors:
Jessica Oesterheld - Bath ME, US
Robert Patterson - Lexington MA, US
Howard Coleman - Seattle WA, US
Robert Patterson - Lexington MA, US
Howard Coleman - Seattle WA, US
Assignee:
GENELEX, INC - Seattle WA
International Classification:
G06Q 50/22
US Classification:
705 2
Abstract:
A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.